Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow Oval 11 mm, Tablet with imprint "ACJ;322". It contains Candesartan cilexetil 32 mg;hydrochlorothiazide 12.5 mg; of Candesartan cilexetil[candesartan];hydrochlorothiazide[hydrochlorothiazide];. This belongs to the Angiotensin 2 receptor blocker pharmacologic class. It is manufactured by AstraZeneca Pharmaceuticals LP. For details please contact your physician.
Basic Information
- Imprint
- ACJ;322
- Color
- Yellow
- Shape
- Oval
- Size
- 11 mm
Drug Information
- Strength
- Candesartan cilexetil 32 mg;hydrochlorothiazide 12.5 mg;
- Dosage Form
- Tablet
- RxCUI
- 805859
Pharmaceutical Classification
- Pharmacologic Class
- Angiotensin 2 receptor blocker
Related Medications
Other drugs in the same class: Angiotensin 2 Receptor Blocker
- ATACANDCANDESARTAN CILEXETIL 16 mg;PINK • ROUND
- ATACANDCANDESARTAN CILEXETIL 32 mg;PINK • ROUND
- ATACANDCANDESARTAN CILEXETIL 4 mg;WHITE • ROUND
- ATACANDCANDESARTAN CILEXETIL 8 mg;PINK • ROUND
- ATACAND HCTCANDESARTAN CILEXETIL 16 mg;HYDROCHLOROTHIAZIDE 12.5 mg;PINK • OVAL
- ATACAND HCTCANDESARTAN CILEXETIL 32 mg;HYDROCHLOROTHIAZIDE 25 mg;PINK • OVAL
- AvaproIRBESARTAN 150 mg;WHITE • OVAL
- AvaproIRBESARTAN 300 mg;WHITE • OVAL
- AvaproIRBESARTAN 75 mg;WHITE • OVAL
- AVAPROirbesartan 150 mg;WHITE • OVAL
Ingredients
- Active Ingredients
- Candesartan cilexetil[candesartan];hydrochlorothiazide[hydrochlorothiazide];
- Inactive Ingredients
- Carboxymethylcellulose calcium;hydroxypropyl cellulose (1600000 wamw);lactose monohydrate;magnesium stearate;starch, corn;polyethylene glycol 8000;ferric oxide yellow;
Additional Information
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Status (Rx/OTC)
- Rx
- Brand Names
- Atacand HCT
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.